A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Conditions: Refractory Autoimmune Diseases Interventions: Genetic: BMS-986515; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Tocilizumab Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb […]
